E-DRUG: WHO Report on the Use of E-Drugs - Revision
---------------------------------------------------
Dear E-drug member,
The WHO Model List of Essential Drugs is revised every
two years. The next meeting of the WHO Expert Committee
on this subject will take place during the first week of
December 1997.
Work is well in hand on the actual revision of the List
with proposals for changes to the List currently being
reviewed by experts.
As secretary of this Committee I am now soliciting comments
as to how the report could be made more useful. In particular,
I would be grateful for any suggestions you may have concerning
the revision and improvement to the introductory sections of
the text of the Technical Report Series which accompanies the
List. Are there any subjects or important points that you
consider missing or superfluous?
I would be most pleased to hear from you before the end of
October.
Dr Mary R. Couper
DSI/DMP/WHO
1211 Geneva 27
Switzerland
Email: couperm@who.ch
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.